A Phase 1/2 Study of the Safety and Efficacy of BRX011 Oral Administration Once Daily in Subjects With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Clinical trial NCT07029945 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07029945
- Sponsor
- Biojiva LLC
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-07
- Primary completion
- 2026-11-11
- Enrollment
- 152
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.